Figure 5From: Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cellsKnockdown of Dicer1e impairs cell proliferation and clonogenicity of oral cancer cells. (A) Western blot analysis of Dicer1 and Dicer1e protein levels in human OSCC cell lines (CAL 27, SCC-4, and SCC-25) 48 hours post-transfection with either control non-targeting siRNA (siNT) or siRNA targeting Dicer1e (siDicer1e). GAPDH was used as a loading control. (B) Cell proliferation assay was performed in OSCC cell lines CAL 27, SCC-4, and SCC-25, after treatment with siDicer1e compared to control siNT-treated cells. Data are mean ± SEM of three separate experiments performed in triplicate, where *P < 0.05 compared to siNT treated cells (Student’s t Test). (C) Assessment of clonogenic potentials of the siDicer1e-treated oral cancer cell lines CAL 27, SCC-4, and SCC-25, compared to control siNT-treated cells. The number of colonies were counted and the data are presented as mean ± SEM of three separate experiments performed in duplicate, where ****P < 0.0001, *P < 0.05 compared to siNT treated cells (Student’s t Test).Back to article page